---  
layout: startup_page  
title: "Aktis Oncology"  
id: "aktisoncology.com"  
permalink: "/aktisoncologyaktisoncology.com09302024/"  
website: "https://www.aktisoncology.com"  
funding_round: "Series B"  
funding_amount: "$175M"  
investors: "RA Capital Management, RTW Investments, Janus Henderson Investors, funds and accounts advised by T. Rowe Price Associates, Inc., Avidity Partners, an undisclosed life sciences-focused investment fund, Bristol Myers Squibb, Eli Lilly and Company, MRL Ventures Fund"  
about: "Aktis Oncology is a clinical-stage biotechnology company developing targeted alpha radiopharmaceuticals for various solid tumors. Their lead program targets Nectin-4, a tumor-associated antigen. The company utilizes a proprietary miniprotein radioconjugate platform designed for maximized tumor killing and minimized side effects."  
markets: "Biotechnology, Oncology, Radiopharmaceuticals, Health Care, Life Science"  
hq: "Boston, Massachusetts, United States"  
founded_year: "2021"  
linkedin: "https://www.linkedin.com/company/aktis-oncology"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/aktis-oncology"  
pitchbook: "https://pitchbook.com/profiles/company/462974-68"  

date_display: "30-Sep-2024"  
date: "2024-09-30"

# SEO Optimization  
meta_title: "Aktis Oncology - Series B Funding ($175M)"  
meta_description: "Aktis Oncology, Aktis Oncology is a clinical-stage biotechnology company developing targeted alpha radiopharmaceuticals for various solid tumors. Their lead program t..."  
meta_keywords: "Aktis Oncology, Biotechnology, Oncology, Radiopharmaceuticals, Health Care, Life Science, Series B funding"  
canonical_url: "https://startup.projectstartups.com/aktisoncologyaktisoncology.com09302024/"  
---